171 related articles for article (PubMed ID: 21495868)
1. Epigenetic screening in product safety assessment: are we there yet?
Rasoulpour RJ; LeBaron MJ; Ellis-Hutchings RG; Klapacz J; Gollapudi BB
Toxicol Mech Methods; 2011 May; 21(4):298-311. PubMed ID: 21495868
[TBL] [Abstract][Full Text] [Related]
2. The dynamic epigenome and its implications in toxicology.
Szyf M
Toxicol Sci; 2007 Nov; 100(1):7-23. PubMed ID: 17675334
[TBL] [Abstract][Full Text] [Related]
3. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
Reamon-Buettner SM; Borlak J
Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic mechanisms in metal toxicity.
Fragou D; Fragou A; Kouidou S; Njau S; Kovatsi L
Toxicol Mech Methods; 2011 May; 21(4):343-52. PubMed ID: 21495872
[TBL] [Abstract][Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
6. Small RNA-mediated epigenetic modifications in plants.
Simon SA; Meyers BC
Curr Opin Plant Biol; 2011 Apr; 14(2):148-55. PubMed ID: 21159545
[TBL] [Abstract][Full Text] [Related]
7. [Epigenetics and environmental exposure to xenobiotics].
Ficociello B; Sturchio E; Minoia C; Casorri L; Imbriani P; Signorini S
G Ital Med Lav Ergon; 2010; 32(1):13-22. PubMed ID: 20464973
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the cancer imprintome.
Monk D
Brief Funct Genomics; 2010 Jul; 9(4):329-39. PubMed ID: 20551091
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
Koturbash I; Beland FA; Pogribny IP
Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
Csoka AB; Szyf M
Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
Tost J
Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
[TBL] [Abstract][Full Text] [Related]
15. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the epigenetic code of cancer for therapy.
Smith LT; Otterson GA; Plass C
Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
[TBL] [Abstract][Full Text] [Related]
18. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer.
Eilertsen KJ; Power RA; Harkins LL; Misica P
Anim Reprod Sci; 2007 Mar; 98(1-2):129-46. PubMed ID: 17166676
[TBL] [Abstract][Full Text] [Related]
19. Maternal care, the epigenome and phenotypic differences in behavior.
Szyf M; Weaver I; Meaney M
Reprod Toxicol; 2007 Jul; 24(1):9-19. PubMed ID: 17561370
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
